Erjiang Zhao

482 citations
22 papers · 351 indexed · h-index 12
Topics
Glutathione Transferases and Polymorphisms (5 papers)Esophageal Cancer Research and Treatment (4 papers)Esophageal and GI Pathology (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Erjiang Zhao

22 papers receiving 350 citations

Peers

Erjiang Zhao
Comparison fields: 5 of 76
  • Molecular Biology 158
  • Oncology 94
  • Surgery 85
  • Pulmonary and Respiratory Medicine 72
  • Cancer Research 53
Replace S. Natsukawa with:
S. Natsukawa Japan
Kozo Shaura Japan
Tomohiko Ohashi Japan
Kuo‐Liang Wei Taiwan
C Couillault France
Kyveli Angelou Greece
Hiroyuki Hisai Japan
Yu‐Tang Gao China
Philipp Houben Germany
Alia Albawardi United Arab Emirates
Erjiang Zhao relative to S. Natsukawa Japan S. Natsukawa's profile →
Citations per field
00.5×6.8×
S. Natsukawa · 1×
Citations per year

Countries citing papers authored by Erjiang Zhao

Since Specialization
Citations

This map shows the geographic impact of Erjiang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erjiang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erjiang Zhao more than expected).

Fields of papers citing papers by Erjiang Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erjiang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erjiang Zhao. The network helps show where Erjiang Zhao may publish in the future.

Co-authorship network of co-authors of Erjiang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Erjiang Zhao. A scholar is included among the top collaborators of Erjiang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erjiang Zhao. Erjiang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 37
2 16
3 9
4 36
5 18
6 5
7 7
8 16
9 11
10 28
11 3
12 26
13 4
14 9
15
Lack of association between GSTP1 Ile105Val polymorphism and coronary heart disease risk: a meta-analysis.
2
16 11
17 3
18 11
19 22
20 31

About Erjiang Zhao

Erjiang Zhao is a scholar working on Cancer Research, Rheumatology and Hepatology, having authored 22 papers that have together received 351 indexed citations. Recurring topics across this work include Glutathione Transferases and Polymorphisms (5 papers), Esophageal Cancer Research and Treatment (4 papers) and Esophageal and GI Pathology (4 papers). The work is most often cited by research in Cancer Research (53 citations), Oncology (94 citations) and Biochemistry (14 citations). Erjiang Zhao has collaborated with scholars based in China and United States. Frequent co-authors include Ling Yuan, Yan Zhao, Dan Cui, Yacong Bo, Hai-Liang Li, Junli Ma, Jian-Ge Qiu, Feng-Mei Zhou, Kunlun Wang and Bing‐Hua Jiang. Their work appears in journals such as International Journal of Cancer, Medicine and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026